These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer. van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615 [TBL] [Abstract][Full Text] [Related]
6. Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening. Cheng HR; van Vorstenbosch RWR; Pachen DM; Meulen LWT; Straathof JWA; Dallinga JW; Jonkers DMAE; Masclee AAM; Schooten FV; Mujagic Z; Smolinska A Clin Transl Gastroenterol; 2022 Nov; 13(11):e00518. PubMed ID: 35981245 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study. Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485 [TBL] [Abstract][Full Text] [Related]
8. Exhaled volatile organic compounds in the detection of colorectal cancer: a systematic review and meta-analysis. Alsaadi D; Clements N; Gabuniya N; Francis N; Chand M EXCLI J; 2024; 23():795-810. PubMed ID: 38983779 [TBL] [Abstract][Full Text] [Related]
9. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results. Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545 [No Abstract] [Full Text] [Related]
10. Potential role of volatile organic compound breath testing in the Australasian colorectal cancer pathway. Gower H; Danielson K; Dennett APE; Deere J ANZ J Surg; 2023 May; 93(5):1159-1161. PubMed ID: 36629356 [TBL] [Abstract][Full Text] [Related]
11. Chemiresistive Sensor Array with Nanostructured Interfaces for Detection of Human Breaths with Simulated Lung Cancer Breath VOCs. Shang G; Dinh D; Mercer T; Yan S; Wang S; Malaei B; Luo J; Lu S; Zhong CJ ACS Sens; 2023 Mar; 8(3):1328-1338. PubMed ID: 36883832 [TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer Detected by Machine Learning Models Using Conventional Laboratory Test Data. Li H; Lin J; Xiao Y; Zheng W; Zhao L; Yang X; Zhong M; Liu H Technol Cancer Res Treat; 2021; 20():15330338211058352. PubMed ID: 34806496 [No Abstract] [Full Text] [Related]
13. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up. Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677 [TBL] [Abstract][Full Text] [Related]
14. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review. Oakley-Girvan I; Davis SW Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925 [TBL] [Abstract][Full Text] [Related]
15. Alteration of the Exhaled Volatile Organic Compound Pattern in Colorectal Cancer Patients after Intentional Curative Surgery-A Prospective Pilot Study. Hanevelt J; Schoenaker IJH; Brohet RM; Schrauwen RWM; Baas FJN; Tanis PJ; van Westreenen HL; de Vos Tot Nederveen Cappel WH Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835479 [TBL] [Abstract][Full Text] [Related]
16. Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review. Song D; Wang F; Ju Y; He Q; Sun T; Deng W; Ding R; Zhang C; Xu Q; Qi C; Bao J Int J Surg; 2023 Apr; 109(4):925-935. PubMed ID: 36974713 [TBL] [Abstract][Full Text] [Related]
17. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis. van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079 [TBL] [Abstract][Full Text] [Related]
18. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
19. The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study. Chandran D; Ooi EH; Watson DI; Kholmurodova F; Jaenisch S; Yazbeck R Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31242578 [No Abstract] [Full Text] [Related]
20. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results. De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]